Abstract Purpose After SARS‐CoV‐2 infection, some patients develop post‐COVID condition (PCC), often associated with sympathicotonia. This study aimed to characterize sympathicotonia in PCC patients using a novel long‐term electrodermal activity (EDA) analysis via a smart ring and evaluate its clinical applicability. Methods Seventeen PCC patients were recruited from a Long Covid outpatient clinic, and 18 healthy controls volunteered. PCC patients were divided based on self‐reported symptoms into those with or without sympathicotonia. A 14‐day EDA monitoring was conducted. Sympathetic nervous system (SNS) activity was expressed as a double normalized index of electrodermal activity (DNE), with higher levels indicating higher SNS activity. Orthostatic tests were performed to identify orthostatic sympathicotonia. DNE levels, representing EDA, were compared to self‐reported and orthostatic sympathicotonia. Results DNE levels did not differ between PCC patients with ( N = 12) or without ( N = 5) self‐reported sympathicotonia or compared with nonsympathetic controls. When dividing all participants by orthostatic test results, DNE levels were lower during day (08:00–14:00; p < 0.05) but higher during late night (00:00–02:00; p < 0.05) in those with orthostatic sympathicotonia ( N = 21) compared to those without ( N = 14), with the 24‐h comparison significant ( p = 0.022). Among PCC patients, DNE levels were higher in orthostatic nonsympathicotonic ( N = 7) than orthostatic sympathicotonic ( N = 10) during morning (09:00–12:00; p < 0.05), with the 24‐h comparison significant ( p = 0.044). Conclusion Self‐reported symptoms did not distinguish sympathicotonia. However, individuals with orthostatic test‐identified sympathicotonia had heightened EDA, indicating increased sympathetic activity, particularly during late night. PCC was not identifiable by EDA. Long‐term EDA monitoring may provide an objective tool for detecting sympathicotonia independently of self‐reported symptoms.